These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 20048377)
1. Cancer therapy costs influence treatment: a national survey of oncologists. Neumann PJ; Palmer JA; Nadler E; Fang C; Ubel P Health Aff (Millwood); 2010; 29(1):196-202. PubMed ID: 20048377 [TBL] [Abstract][Full Text] [Related]
2. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077 [TBL] [Abstract][Full Text] [Related]
3. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey. Schrag D; Hanger M J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946 [TBL] [Abstract][Full Text] [Related]
4. Cost issues in new disease-modifying treatments for advanced cancer: in-depth interviews with physicians. de Kort SJ; Kenny N; van Dijk P; Gevers S; Richel DJ; Willems DL Eur J Cancer; 2007 Sep; 43(13):1983-9. PubMed ID: 17616456 [TBL] [Abstract][Full Text] [Related]
5. Do oncologists believe new cancer drugs offer good value? Nadler E; Eckert B; Neumann PJ Oncologist; 2006 Feb; 11(2):90-5. PubMed ID: 16476830 [TBL] [Abstract][Full Text] [Related]
6. An international pilot study of oncology physicians' opinions and practices on Complementary and Alternative Medicine (CAM). Lee RT; Hlubocky FJ; Hu JJ; Stafford RS; Daugherty CK Integr Cancer Ther; 2008 Jun; 7(2):70-5. PubMed ID: 18505899 [TBL] [Abstract][Full Text] [Related]
7. Oncologists' attitudes to treatment of cancer patients. Gilbar O; Cohen BZ Death Stud; 1995; 19(4):303-13. PubMed ID: 10160548 [TBL] [Abstract][Full Text] [Related]
8. Factors which motivate cancer doctors to involve their patients in reaching treatment decisions. Shepherd HL; Butow PN; Tattersall MH Patient Educ Couns; 2011 Aug; 84(2):229-35. PubMed ID: 21112174 [TBL] [Abstract][Full Text] [Related]
9. How physicians react to cost-effectiveness information. Asch DA LDI Issue Brief; 2003; 8(9):1-4. PubMed ID: 12956120 [TBL] [Abstract][Full Text] [Related]
10. Physician consideration of patients' out-of-pocket costs in making common clinical decisions. Pham HH; Alexander GC; O'Malley AS Arch Intern Med; 2007 Apr; 167(7):663-8. PubMed ID: 17420424 [TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology guidance statement: the cost of cancer care. Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE; J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533 [TBL] [Abstract][Full Text] [Related]
12. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings. Sneed RC; May WL; Stencel C Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092 [TBL] [Abstract][Full Text] [Related]
13. Physician attitudes toward personal relationships with patients. Regan S; Ferris TG; Campbell EG Med Care; 2010 Jun; 48(6):547-52. PubMed ID: 20473214 [TBL] [Abstract][Full Text] [Related]
15. Cost-consciousness among Swiss doctors: a cross-sectional survey. Bovier PA; Martin DP; Perneger TV BMC Health Serv Res; 2005 Nov; 5():72. PubMed ID: 16281977 [TBL] [Abstract][Full Text] [Related]
16. Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology. Kuerer HM; Eberlein TJ; Pollock RE; Huschka M; Baile WF; Morrow M; Michelassi F; Singletary SE; Novotny P; Sloan J; Shanafelt TD Ann Surg Oncol; 2007 Nov; 14(11):3043-53. PubMed ID: 17828575 [TBL] [Abstract][Full Text] [Related]
17. Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors. Siminoff LA; Graham GC; Gordon NH Patient Educ Couns; 2006 Sep; 62(3):355-60. PubMed ID: 16860520 [TBL] [Abstract][Full Text] [Related]
18. Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey. Shrank WH; Young HN; Ettner SL; Glassman P; Asch SM; Kravitz RL Am J Manag Care; 2005 Jan; 11(1):16-22. PubMed ID: 15697096 [TBL] [Abstract][Full Text] [Related]
19. The negative impact of stark law exemptions on graduate medical education and health care costs: the example of radiation oncology. Anscher MS; Anscher BM; Bradley CJ Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1289-94. PubMed ID: 20338471 [TBL] [Abstract][Full Text] [Related]
20. Cost of cancer care: issues and implications. Meropol NJ; Schulman KA J Clin Oncol; 2007 Jan; 25(2):180-6. PubMed ID: 17210937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]